Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-06

Clinical Trial Update: Psilocybin With Intracranial Neural Sensing [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for psilocybin combined with intracranial neural sensing in chronic pain; enrollment is ongoing by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Joshua Woolley, MD, PhD | Conditions: Chronic Pain | Phase 1 | Status: ENROLLING_BY_INVITATION